Skip to content

Aortic lesions after Radiofrequency and Cryoballoon Therapy In patients undergoing Catheter ablation of Atrial Fibrillation

Aortic lesions after Radiofrequency and Cryoballoon Therapy In patients undergoing Catheter ablation of Atrial Fibrillation - ARCTIC AF

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013510
Enrollment
60
Registered
2017-12-04
Start date
2018-01-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.0

Interventions

Group 1: Patients with paroxysmal atrial fibrillation randomized to the cryo-ablation group receive aortic MRI 24h prior to ablation and cryo-ablation at the following day. The day after the procedur

Sponsors

Herzzentrum Köln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Included are all patients (> 18 years) undergoing pulmonary vein isolation using radiofrequency energy or cryo-energy within the planned study period of 12 months and agreeing to participate in the study. It is planned to include 60 ablated patients (1: 1, 30 patients with RF ablation and 30 patients with cryoballoon therapy.

Exclusion criteria

Exclusion criteria: There should be no contraindications for anticoagulation or magnetic resonance imaging.

Design outcomes

Primary

MeasureTime frame
The aim of the study is to optimize the safety of pulmonary venin insolation performed by cryogenic or radiofrequency energy with respect to aortic lesions. The endpoint is the detection of aortic lesions after radiofrequency or cryo ablation. The first aortic MRI is planned on the day before ablation and serves as a baseline, then the procedure itself is performed on the following day. The second MRI is performed on the first postoperative day.

Secondary

MeasureTime frame
Collection of predictors that favor aortic lesions.

Countries

Germany

Contacts

Public ContactBarbara Bellmann

Herzzentrum der Uniklinik Köln

barbara.bellmann@uk-koeln.de0049 221 47832396

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026